Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionAtlas Capital Advisors Llc
Latest Disclosed Ownership905 shares
Latest Disclosed Value $ 36,480
Atlas Capital Advisors Llc ownership in HTD / Corcept Therapeutics Incorporated

On May 11, 2026 - Atlas Capital Advisors Llc filed a 13F-HR form disclosing ownership of 905 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $31,213 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 905 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $57,232 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Corcept Therapeutics Equity 218352102 905 0 0.00 36 16.13 0.0040
2026-02-13 2025-12-31 13F Corcept Therapeutics Equity 218352102 905 0 0.00 31 -53.03 0.0035
2025-08-12 2025-06-30 13F Corcept Therapeutics Equity 218352102 905 -10,000 -91.70 66 -94.70 0.0081
2025-05-12 2025-03-31 13F Corcept Therapeutics Equity 218352102 10,905 0 0.00 1,246 126.78 0.1556
2025-02-12 2024-12-31 13F Corcept Therapeutics Equity 218352102 10,905 10,905 550 0.0698
2024-11-05 2024-09-30 13F Corcept Therapeutics Equity 218352102 0 -10,905 -100.00 0 -100.00
2024-11-05 2024-09-30 13F Corcept Therapeutics Equity 218352102 0 0
2024-07-30 2024-06-30 13F Corcept Therapeutics Equity 218352102 10,905 10,905 354 0.0460
2024-04-15 2024-03-31 13F Corcept Therapeutics Equity 218352102 0 -10,905 -100.00 0 -100.00
2024-02-15 2023-12-31 13F Corcept Therapeutics Equity 218352102 10,905 0 0.00 354 19.19 0.0513
2023-11-14 2023-09-30 13F Corcept Therapeutics Equity 218352102 10,905 0 0.00 297 22.73 0.0489
2023-08-15 2023-06-30 13F Corcept Therapeutics Equity 218352102 10,905 0 0.00 243 2.54 0.0368
2023-05-16 2023-03-31 13F Corcept Therapeutics Equity 218352102 10,905 0 0.00 236 6.79 0.0372
2023-02-15 2022-12-31 13F Corcept Therapeutics US Mid Cap 218352102 10,905 0 0.00 221 -20.79 0.0372
2022-11-08 2022-09-30 13F Corcept Therapeutics US Mid Cap 218352102 10,905 0 0.00 280 7.72 0.0509
2022-08-16 2022-06-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 259 5.71 0.0439
2022-05-11 2022-03-31 13F Corcept Therapeutics US Large Cap 218352102 10,905 0 0.00 246 13.95 0.0381
2022-02-01 2021-12-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 216 0.47 0.0322
2021-10-28 2021-09-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 215 -10.46 0.0344
2021-07-30 2021-06-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 240 -7.72 0.0402
2021-05-10 2021-03-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 259 -9.12 0.0504
2021-02-16 2020-12-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 285 50.79 0.0600
2020-10-23 2020-09-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 190 3.28 0.0449
2020-07-28 2020-06-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 183 41.86 0.0430
2020-05-04 2020-03-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 130 -1.53 0.0386
2020-01-28 2019-12-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 132 -14.94 0.0329
2019-10-31 2019-09-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 154 27.27 0.0463
2019-07-25 2019-06-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 122 -5.47 0.0399
2019-04-29 2019-03-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 128 -11.72 0.0462
2019-01-29 2018-12-31 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 146 -8.23 0.0584
2018-11-09 2018-09-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 0 0.00 158 4.64 0.0528
2018-07-30 2018-06-30 13F Corcept Therapeutics US Small Cap 218352102 10,905 905 9.05 152 -7.93 0.0538
2018-04-17 2018-03-31 13F Corcept Therapeutics US Small Cap 218352102 10,000 10,000 164 0.0505
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.